Objectives: A comprehensive understanding of attitudes and changes in attitudes towards cancer pain and opioid analgesics among cancer patients can help healthcare professionals to provide more targeted and effective health education to improve the quality of care and health education for patients with cancer pain.
Methods: A cross-sectional study was conducted from January 2013 to December 2013 and from January 2023 to December 2023, respectively. Questionnaires were used to collect data, including the clinical characteristics of patients and their perspectives on cancer pain and opioids. A propensity score matching (PSM) analysis was performed to balance the baseline characteristics.
Results: A total of 894 patients were enrolled in this study, 474 patients in 2013 and 420 patients in 2023. After PSM, 600 patients were included in this analysis. Over the course of a decade, an increasing number of patients were able to accept cancer pain management, opioid medication, and adverse events of opioids. With regard to opioid analgesics, patients' primary concern had shifted over the decade from addiction to the analgesic effect of opioids. Although understanding of opioids had improved over a decade, the vast majority of the population was still poorly informed about opioids. In addition, approximately 90% of participants believed that their education about opioids was insufficient.
Conclusions: Over a decade, although patients had more positive attitudes towards cancer pain management, their knowledge and health education about cancer pain was poor. This finding suggests that health professionals should work together to disseminate knowledge about cancer pain and strengthen health education to manage cancer pain well and improve the quality of life of cancer patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11887091 | PMC |
| http://dx.doi.org/10.1186/s12885-025-13594-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy of a Supervised Exercise Program on Pain, Physical Function, and Quality of Life in Patients With Breast Cancer: Protocol for a Randomized Clinical Trial.
JMIR Res Protoc
March 2025
Paseo de los Encomendadores, Faculty of Health Sciences, University of Burgos, Burgos, Spain.
Background: Breast cancer is the second most common cancer in women worldwide. Treatments for this disease often result in side effects such as pain, fatigue, loss of muscle mass, and reduced quality of life. Physical exercise has been shown to effectively mitigate these side effects and improve the quality of life in patients with breast cancer.
View Article and Find Full Text PDFPharmacist interventions in optimising opioid medication therapy in pain management for palliative care patients: A systematic review.
J Oncol Pharm Pract
March 2025
Department of Pharmacy Management, Faculty of Pharmacy, Gazi University, 06330, Ankara, Türkiye.
BackgroundOpioid therapy is a critical component in managing pain in palliative care, where pharmacists' specialised expertise is crucial in ensuring quality care for patients. This systematic review aims to document available evidence on pharmacist interventions and their impact on optimising opioid therapy for pain management in palliative care patients.MethodsWe searched Medline (OVID), Embase (OVID), APA PsycINFO and Cochrane Central Register of Controlled Trials (CENTRAL) for relevant articles published from the beginning to 31 December, 2022.
View Article and Find Full Text PDFComparison of health-related quality of life trajectories in older breast cancer survivors and noncancerous controls over 10 years: A SEER-MHOS analysis.
J Cancer Surviv
March 2025
Department of Health Sciences, University of Central Florida College of Health Professions and Sciences, 4364 Scorpius Street, Orlando, FL, USA.
Purpose: This study analyzed the long-term effects of cancer on the health-related quality of life (HRQOL) of older breast cancer survivors for 10 years, including a control group to distinguish between the impacts of cancer treatment and aging.
Methods: The SEER-MHOS data resource was used in the analysis. Cases were 674 older women diagnosed with breast cancer in 1998-2015 at age 65 and older and participated in Medicare Health Outcomes Survey within 24 months before their cancer diagnosis and at least once within 10 years of post-diagnosis.
Naldemedine Use and Healthcare Resource Utilization in Patients treated with Opioid Analgesics for Chronic Non-Cancer Pain: Results of a Real-world Study in the USA.
Pain Ther
March 2025
Unit of Internal Medicine, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Rome, Italy.
Introduction: Opioid-induced constipation (OIC) is a common side effect of chronic opioid therapy that significantly impacts quality of life and healthcare costs. Naldemedine, a peripherally acting mu-opioid receptor antagonist, has shown efficacy in treating OIC. However, real-world evidence on naldemedine use in the United States is limited, particularly in older adults.
View Article and Find Full Text PDFThe impact of combined Gua Sha and myofascial release techniques on upper limb dysfunction in patients with breast cancer and axillary web syndrome: a prospective case series study.
Support Care Cancer
March 2025
Department of Breast Surgery, Jiangsu Province Hospital, No. 368 Jiangdong North Road, Gulou District, Nanjing City, 210000, Jiangsu Province, China.
Objective: To investigate the effects of a combined Gua Sha and myofascial release approach on upper limb dysfunction in patients with breast cancer and axillary web syndrome (AWS).
Methods: In this prospective case series study, 30 patients with breast cancer diagnosed with AWS post-surgery were recruited. Participants underwent a 12-week intervention combining Gua Sha and myofascial release techniques.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!